For all the attention on U.S.-China AI competition, new studies point to China's rapid rise in biotechnology, especially for drug and agricultural development.
  • dan1101@lemm.ee
    141·
    3 days ago

    Nice to see what can be accomplished in a country that isn’t openly hostile to science.

    • lightrush@lemmy.caOP
      121·
      3 days ago

      And long term economic planning, and therefore public investment in science.

  • lightrush@lemmy.caOP
    62·
    3 days ago

    China’s biotech industry has evolved to the point that U.S. and European pharmaceutical giants in the last several months have spent billions to acquire China-developed drugs that could treat cancer if commercialized with regulatory approval. In March, British pharmaceutical giant AstraZeneca announced it will invest $2.5 billion in a research and development center in Beijing.

    In case you thought research isn’t subject to outsourcing.